Prospects for AI clinical summarization to reduce the burden of patient chart review.

Effective summarization of unstructured patient data in electronic health records (EHRs) is crucial for accurate diagnosis and efficient patient care, yet clinicians often struggle with information overload and time constraints. This review dives into recent literature and case studies on both the significant impacts and outstanding issues of patient chart review on communications, diagnostics, and management. It also discusses recent efforts to integrate artificial intelligence (AI) into clinical summarization tasks, and its transformative impact on the clinician's potential, including but not limited to reductions of administrative burden and improved patient-centered care.

Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy.

BRAF-targeted kinase inhibitors (KIs) are used to treat malignancies including BRAF-mutant non-small cell lung cancer, colorectal cancer, anaplastic thyroid cancer, and, most prominently, melanoma. However, KI selection criteria in patients remain unclear, as are pharmacokinetic/pharmacodynamic (PK/PD) mechanisms that may limit context-dependent efficacy and differentiate related drugs. To address this issue, we imaged mouse models of BRAF-mutant cancers, fluorescent KI tracers, and unlabeled drug to calibrate in silico spatial PK/PD models.